2020
DOI: 10.1055/s-0039-1690740
|View full text |Cite
|
Sign up to set email alerts
|

Transition-Metal-Catalyzed Suzuki–Miyaura-Type Cross-Coupling Reactions of π-Activated Alcohols

Abstract: The Suzuki–Miyaura reaction is one of the most powerful tools for the formation of carbon–carbon bonds in organic synthesis. The utilization of alcohols in this powerful reaction is a challenging task. This short review covers progress in the transition-metal-catalyzed Suzuki­–Miyaura-type cross-coupling reaction of π-activated alcohol, such as aryl, benzylic, allylic, propargylic and allenic alcohols, between 2000 and June 2019.1 Introduction2 Suzuki–Miyaura Cross-Coupling Reactions of Aryl Alcohols2.1 One… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 35 publications
0
7
0
Order By: Relevance
“…The ubiquity of alcohols across most classes of molecules makes them attractive as potential C­(sp 3 ) coupling partners. However, on account of the relatively strong bond dissociation energy of the C–O bond and low leaving ability of the OH – group, alcohols are seldom directly employed as alkylating agents in cross-couplings, with a notable exception being π-activated allylic and benzylic alcohols. Although many alcohol derivatives have been wildly studied in reductive cross-coupling reactions, including alkyl acetates, , tosylates, xanthate esters, mesylates, pivalates, oxalates, phosphates, methyl ethers, and chloroformates (Figure A, right), such derivatives require preparation step(s) from their alcohol precursors, and the substrate scope is often limited to allylic and benzylic alcohol derivatives. Therefore, it would be synthetically appealing to develop a reaction which can directly harness free alcohols to construct C­(sp 2 )–C­(sp 3 ) bonds, ideally supporting both π-activated alcohols and alkyl alcohols as starting materials.…”
Section: Introductionmentioning
confidence: 99%
“…The ubiquity of alcohols across most classes of molecules makes them attractive as potential C­(sp 3 ) coupling partners. However, on account of the relatively strong bond dissociation energy of the C–O bond and low leaving ability of the OH – group, alcohols are seldom directly employed as alkylating agents in cross-couplings, with a notable exception being π-activated allylic and benzylic alcohols. Although many alcohol derivatives have been wildly studied in reductive cross-coupling reactions, including alkyl acetates, , tosylates, xanthate esters, mesylates, pivalates, oxalates, phosphates, methyl ethers, and chloroformates (Figure A, right), such derivatives require preparation step(s) from their alcohol precursors, and the substrate scope is often limited to allylic and benzylic alcohol derivatives. Therefore, it would be synthetically appealing to develop a reaction which can directly harness free alcohols to construct C­(sp 2 )–C­(sp 3 ) bonds, ideally supporting both π-activated alcohols and alkyl alcohols as starting materials.…”
Section: Introductionmentioning
confidence: 99%
“…These protocols typically involve the Friedel–Crafts (FC) alkylation reaction catalyzed by Lewis acidic metals, [ 3 ] the hydrogen borrowing (HB) strategy for the alkylation of classic nucleophiles such as activated methylene compounds, [ 4 ] and the cross‐coupling reactions of activated alcohols and organometallic species. [ 5 ] Progress in this field offers invaluable methods for installing aliphatic fragments into nucleophilic architectures.…”
Section: Introductionmentioning
confidence: 99%
“…Regarding the use of aryl halide-phenol cross-coupling technique, highly functionalized diaryl ethers may be produced in a more straightforward and time-efficient manner. [17][18][19] Diaryl ethers have a variety of applications, i.e. in producing novel materials with improved functionalities, synthesis, and creating new medications.…”
Section: Introductionmentioning
confidence: 99%